Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Prospective Observational Study to Assess the Reproducibility of Minimally Invasive Surgery in the Treatment of Grade III Hemorrhoids: Phase 2A of the IDEAL Framework

NCT07171294 is registered in ClinicalTrials.gov with Hospital Son Llatzer as lead sponsor.

NCT NCT07171294
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT07171294 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Prospective Observational Study to Assess the Reproducibility of Minimally Invasive Surgery in the Treatment of Grade III Hemorrhoids: Phase 2A of the IDEAL Framework
Lead sponsor
Hospital Son Llatzer
Phase
Observational
Overall status
Active, not recruiting
Start date
August 12, 2025
Completion date
September 30, 2026
Enrollment
20 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

hemorrhoidectomy, minimal invasive surgery